Risks and Complications in Patients with Malignant Skin Tumors of the Head and Neck
Otto Alemán Miranda1* and José Jardón Caballero2
1General Clinical and Surgical Hospital Orlando Pantoja Tamayo, Cuba
2General Clinical and Surgical Hospital Provincial Saturnino Lora Torres
*Corresponding Author: Otto Alemán Miranda, General Clinical and Surgical
Hospital Orlando Pantoja Tamayo, Cuba.
Received: November 25, 2022; Published: January 23, 2023
Abstract
The skin is the largest organ of the human body, it fulfills multiple functions that make it an anatomical structure, essential for life. There are multiple conditions that can occur in the Bucco maxillofacial complex from a dermatological point of view. This motivated the realization of the present investigation with the objective of describing the main risks and complications in patients with malignant skin tumors in the head and neck. For this, an exhaustive bibliographic review was carried out based on national and international literature, using different descriptors in English and Spanish. The previous experience of the author was taken into account. A critical analysis was then carried out, highlighting the main risks and complications that may occur in these patients. Illustrations of different therapeutic procedures performed on patients are shown. The content was organized by diagnosis and location of the lesions. At the end of the investigation, it is concluded that there are multiple complications and risks to which these patients are exposed, causing functional, mechanical, aesthetic damage, psychological and nutritional alterations.
Keywords: Dermatology; Oromaxillofacial Manifestation; Orofacial Dermatology
References
- Santana Garay JC. “Atlas of Pathology of the oral complex. Atlas of Pathology of the buccal complex”. 2nd edition Havana: Editorial Medical Sciences (2010).
- Gutierrez M., et al. “Skin flaps in facial cancer surgery”. Skin flaps in facial oncology surgery (2012).
- Fidalgo Rodriguez FT. “Reconstruction of the auricular lobe with a modified bilobed flap”. (2021).
- Álvarez Salafranca M., et al. “Dermoscopy of basal cell carcinoma: updated review”. Actas Dermo-Sifiliográficas (English Edition) (2021).
- Fernández Antón Martínez MC and Suárez Fernández R. “The bilobed flap: a typical flap modified in atypical locations”. Piel, The bilobed flap: a typical flap modified in atypical locations 28.1 (2013): 50-56.
- Álvarez Castillo A., et al. “Systematic review of basal cell carcinoma”. Systematic review of basal cell carcinoma (2020).
- Arquero P. “Restorative and reconstructive treatment of the sequelae of facial surgical pathology. Madrid: SECPRE. Repairing and reconstructive treatment of the sequelae of facial surgical pathology (2013).
- Mustardé JC., et al. “Cirugía reparadora y reconstructora de la región orbital. Barcelona: Toray. Reconstructive and reconstructive surgery of the orbital region (1982).
- Cabrera Naranjo DL., et al. “Carcinoma basocelular tratado con HeberFERON, seguimiento clínico, histológico y ecográfico. Case report. Basal cell carcinoma treated with HeberFERON, clinical, histological and ultrasound follow-up. Case report (2020).
- Rojas Rondón I., et al. “Afecciones palpebrales. Palpebral affections. La Habana: Editorial Ciencias Médicas (2018).
- Rodríguez Fonseca RA., et al. “Tratamiento con HeberFERON® en pacientes con carcinoma basocelular del Hospital Clínico Quirúrgico “Dr. Miguel Enríquez”. Treatment with HeberFERON® in patients with basal cell carcinoma of the Surgical Clinical Hospital (2018).
- Rojas Rondón I., et al. “Concordancia entre el diagnostico clínico y el anatomopatológico de los tumores malignos del párpado. Concordance between clinical and pathological diagnosis of malignant eyelid tumors”. Revista Cubana de Oftalmología 1 (2019): 79-90.
- Wu PA. “Epidemiology, pathogenesis, and clinical features of basal cell carcinoma” (2018).
- Ministerio de Salud Pública. Anuario estadístico de Salud 2018. La Habana: Dirección de Registros Médicos y Estadística de Salud (2019).
- Jonasch E and Frank G. “Interferon in Oncological Practice: Review of InterferonBiology, Clinical Applications, and Toxicities”. The Oncology1 (2001): 34-55.
- Piña Rodríguez Y., et al. “Dermatoscopia para establador márgenes quirúrgicos mínimos en la resección de carcinomas basocelulares. Dermatoscopy to establish minimum surgical margins in the resection of basal cell carcinomas”. Revista Médica Electrónica (2018).
- Bello Rivero I., et al. “HeberFERON, a new formulation of IFNs with improved pharmacodynamics: Perspective for cancer treatment”. Seminars in Oncology1-2 (2018): 27-33.
- Becquart O and Guillot B. “Carcinoma epidermoide cutaneous y sus precursores”. EMC - Dermatología (2020).
- Cañueto J., et al. “A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis”. Actas Dermosifiliogr4 (2020): 281-290.
- Cirugía de Cabeza y cuello. Dr. Robert A. Wise, Dr. Harvey W. Baker. 3rd [Nueva Editorial Interamericana? (2019).
Citation
Copyright